Cardiovascular disease
Up one level-
Prenatal events may predispose to later cardiovascular risk - Relation Between the Metabolic Syndrome and Ischemic Stroke or Transient Ischemic Attack. A Prospective Cohort Study in Patients With Atherosclerotic Cardiovascular Disease.
- Prevalence and Impact of Metabolic Syndrome on Hospital Outcomes in Acute Myocardial Infarction
- Relation of the metabolic syndrome to calcified atherosclerotic plaque in the coronary arteries and aorta
- Metabolic Syndrome and Diabetes Are Associated With an Increased Likelihood of Inducible Myocardial Ischemia Among Patients With Subclinical Atherosclerosis
- High prevalence of metabolic syndrome among young women with nonfatal myocardial infarction.
- Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey
- NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older.
- Cardiovascular risk assessment in metabolic syndrome: view from PROCAM.
- The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study.
- The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).
- Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity.
- Which features of the metabolic syndrome predict the prevalence and clinical outcomes of angiographic coronary artery disease?
- The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
- Cardiovascular morbidity and mortality associated with the metabolic syndrome.
- Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease.
- Clinical review 163: Cardiovascular endocrinology: Low-density lipoprotein size and cardiovascular disease: a reappraisal.
- The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations
- The metabolic syndrome as independent predictor of poor coronary collaterals in patients with total right coronary artery occlusion - (11/05/06)
- Metabolic syndrome associated with faster disease progression and worse prognosis in patients with aortic stenosis (AS) - (03/07/06)
- High prevalence of metabolic risk factors in South African blacks with coronary artery disease - (05/07/06)
- Increased left ventricular mass associated with reduced left ventricular (LV) performance in obese adolescents - (06/07/06)
- ApoB/apoAI ratio as best marker of coronary artery disease in clinical practice - (25/08/06)
- Development and validation of the Reynolds Risk Score for the assessment of global cardiovascular risk in women - (28/03/07)
